These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30234833)

  • 21. Management of impending necrosis associated with soft tissue filler injections.
    Dayan SH; Arkins JP; Mathison CC
    J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
    Lee W; Oh W; Ko HS; Lee SY; Kim KW; Yang EJ
    Plast Reconstr Surg; 2019 Jul; 144(1):137-143. PubMed ID: 31246817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrobulbar Injection for Hyaluronic Acid Gel Filler-Induced Blindness: A Review of Efficacy and Technique.
    Surek CC; Said SA; Perry JD; Zins JE
    Aesthetic Plast Surg; 2019 Aug; 43(4):1034-1040. PubMed ID: 31065750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review.
    Navarro-Hernandez E; Pérez-López M
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Sep; 97(9):521-538. PubMed ID: 35787383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update in Soft-Tissue Filler-Associated Blindness.
    Sorensen EP; Council ML
    Dermatol Surg; 2020 May; 46(5):671-677. PubMed ID: 31490297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular Complications Following Autologous Fat Injections into Facial Area: Case Report of a Recovery from Visual Loss After Ophthalmic Artery Occlusion and a Review of the Literature.
    Szantyr A; Orski M; Marchewka I; Szuta M; Orska M; Zapała J
    Aesthetic Plast Surg; 2017 Jun; 41(3):580-584. PubMed ID: 28233134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anterior filler displacement following injection of calcium hydroxylapatite gel (Radiesse) for anophthalmic orbital volume augmentation.
    Buchanan AG; Holds JB; Vagefi MR; Bidar M; McCann JD; Anderson RL
    Ophthalmic Plast Reconstr Surg; 2012; 28(5):335-7. PubMed ID: 22965013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler.
    Sung MS; Kim HG; Woo KI; Kim YD
    Ophthalmic Plast Reconstr Surg; 2010; 26(4):289-91. PubMed ID: 20523258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual impairment by multiple vascular embolization with hydroxyapatite particles.
    Marumo Y; Hiraoka M; Hashimoto M; Ohguro H
    Orbit; 2018 Jun; 37(3):165-170. PubMed ID: 29023217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining the Role of Retrobulbar Hyaluronidase in Reversing Filler-Induced Blindness: A Systematic Review.
    Paap MK; Milman T; Ugradar S; Goldberg R; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):231-238. PubMed ID: 31880685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injectable calcium hydroxylapatite for correction of nasal bridge deformities.
    Siclovan HR; Jomah JA
    Aesthetic Plast Surg; 2009 Jul; 33(4):544-8. PubMed ID: 19067034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blindness after calcium hydroxylapatite injection at nose.
    Chang TY; Pan SC; Huang YH; Hsueh YY
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1755-7. PubMed ID: 24997507
    [No Abstract]   [Full Text] [Related]  

  • 33. Eyelid mass secondary to injection of calcium hydroxylapatite facial filler.
    Lee MJ; Sung MS; Kim NJ; Choung HK; Khwarg SI
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):421-3. PubMed ID: 18806674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to make calcium hydroxylapatite injections safer.
    Aguilera SB; Tivoli YA; Seastrom SJ
    J Drugs Dermatol; 2014 Sep; 13(9):1015. PubMed ID: 25225999
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention and management of iatrogenic blindness associated with aesthetical filler injections.
    de Lacerda D
    Dermatol Ther; 2018 Nov; 31(6):e12722. PubMed ID: 30253011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.
    Kim YK; Jung C; Woo SJ; Park KH
    J Korean Med Sci; 2015 Dec; 30(12):1847-55. PubMed ID: 26713062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden vision loss and neurological deficits after facial hyaluronic acid filler injection.
    Lucaciu A; Samp PF; Hattingen E; Kestner RI; Davidova P; Kohnen T; Rudolph J; Dietz A; Steinmetz H; Strzelczyk A
    Neurol Res Pract; 2022 Jul; 4(1):40. PubMed ID: 35850779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retro or PeriBulbar Injection Techniques to Reverse Visual Loss After Filler Injections.
    Carruthers J; Fagien S; Dolman P
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S354-7. PubMed ID: 26618464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmic Artery Occlusion and Subsequent Retinal Fibrosis From a Calcium Hydroxylapatite Filler Injection.
    Oh DJ; Jiang Y; Mieler WF
    J Vitreoretin Dis; 2019 May; 3(3):190-193. PubMed ID: 31131349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.